The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Chutko L.S.

Institut mozga cheloveka RAN im. N.P. Bekhterevoĭ, Sankt-Peterburg;
Sankt-Peterburgskaia gosudarstvennaia pediatricheskaia meditsinskaia akademiia

Surushkina S.Yu.

Institut mozga cheloveka RAN im. N.P. Bekhterevoĭ, Sankt-Peterburg;
Sankt-Peterburgskaia gosudarstvennaia pediatricheskaia meditsinskaia akademiia

Iakovenko E.A.

Institut mozga cheloveka RAN im. N.P. Bekhterevoĭ, Sankt-Peterburg

Anisimova T.I.

Institut mozga cheloveka RAN im. N.P. Bekhterevoĭ, Sankt-Peterburg;
Sankt-Peterburgskaia gosudarstvennaia pediatricheskaia meditsinskaia akademiia

Sergeev A.V.

Chair of biophysical methods in medicine, Faculty of continuing medical education of the Russian University of Peoples’ Friendship;
G.N. Speransky Children's Clinical Hospital №9

Emotional impairments and their correction in patients with migraine

Authors:

Chutko L.S., Surushkina S.Yu., Iakovenko E.A., Anisimova T.I., Sergeev A.V.

More about the authors

Journal: Therapeutic Archive. 2017;89(4): 75‑79

DOI: 10.17116/terarkh201789475-79

Read: 5837 times

Download PDF (RU)
Contact the author
Table of contents

EMOTIONAL IMPAIRMENTS AND THEIR CORRECTION IN PATIENTS WITH MIGRAINE
EMOTIONAL IMPAIRMENTS AND THEIR CORRECTION IN PATIENTS WITH MIGRAINE

To cite this article:

Chutko LS, Surushkina SYu, Iakovenko EA, Anisimova TI, Sergeev AV. Emotional impairments and their correction in patients with migraine. Therapeutic Archive. 2017;89(4):75‑79. (In Russ.)
https://doi.org/10.17116/terarkh201789475-79

МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
The role of gene­tic poly­morphisms in folate meta­bolism genes in the mani­festation of migraine in children. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):47-52
Deve­lopment of a diagnostic and treatment algo­rithm for anxiety asso­ciated with soma­tic pathology in patients in gene­ral clinical practice. Reso­lution of the expert council. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):62-69
Biochemical features of migraine pathogenesis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):21-26
Morning headaches in patients with obstructive sleep apnea syndrome: Pathogenesis, differential diagnosis, and treatment. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5-2):92-97
Recu­rrent pain syndromes in adolescents of different ages. Russian Journal of Pain. 2025;(2):24-31
Prophylactic treatment of migraine in real clinical practice. Russian Journal of Pain. 2025;(2):63-69
Biofeedback in complex therapy of pain syndromes. Russian Journal of Pain. 2025;(2):70-75
Vascular endo­thelial growth factor in episodic and chro­nic migraine: new approaches to unde­rstanding pathogenesis. Russian Journal of Pain. 2025;(3):17-21
The Central Sensitization Inve­ntory: modi­fication for tension-type headache, migraine and cervicogenic headache. Russian Journal of Pain. 2025;(3):22-32
Orexin A in migraine: asso­ciations with clinical features of disease and como­rbid diso­rders. Russian Journal of Pain. 2025;(3):42-51
Abstract:

Aim. To study emotional impairments in patients with migraine and to evaluate the efficiency of Noophen therapy for this pathology. Subjects and methods. 63 patients aged 18 to 45 years with migraine without aura were examined. 56 patients used prophylactic antimigraine therapy: Group 1 (n = 26) received metoprolol and Group 2 took metoprolol in combination with Noophen. Results. The patients with migraine had a significantly higher level of alexithymia than the controls. Concomitant anxiety disorders were found in 47 (74.6%) cases. The study provided evidence that the treatment was highly effective in Group 2 that exhibited a more pronounced decrease in pain intensity, a greater reduction in the levels of anxiety, and more vital activity. Conclusion. The results of this study allow a conclusion that emotional impairments are implicated in the pathogenesis and clinical presentations of migraine and that it is appropriate to use Noophen for the treatment of this pathology.

Keywords:

migraine
anxiety disorders
alexithymia
Noophen

Authors:

Chutko L.S.

Institut mozga cheloveka RAN im. N.P. Bekhterevoĭ, Sankt-Peterburg;
Sankt-Peterburgskaia gosudarstvennaia pediatricheskaia meditsinskaia akademiia

Surushkina S.Yu.

Institut mozga cheloveka RAN im. N.P. Bekhterevoĭ, Sankt-Peterburg;
Sankt-Peterburgskaia gosudarstvennaia pediatricheskaia meditsinskaia akademiia

Iakovenko E.A.

Institut mozga cheloveka RAN im. N.P. Bekhterevoĭ, Sankt-Peterburg

Anisimova T.I.

Institut mozga cheloveka RAN im. N.P. Bekhterevoĭ, Sankt-Peterburg;
Sankt-Peterburgskaia gosudarstvennaia pediatricheskaia meditsinskaia akademiia

Sergeev A.V.

Chair of biophysical methods in medicine, Faculty of continuing medical education of the Russian University of Peoples’ Friendship;
G.N. Speransky Children's Clinical Hospital №9

Close metadata

References:

  1. Tabeeva GR, Yakhno NN. Migren'. M.: GEOTAR-Media; 2011. (In Russ.)
  2. Mattsson P, Ekselius L. Migraine, major depression, panic disorder, and personality traits in women aged 40-74 years: a population-based study. CNS Neurosci Ther. 2010;16(2):76-82. doi:10.1111/j.1755-5949.2009.00103.x
  3. Aleksander F. Psikhosomaticheskaya meditsina: Printsipy i primenenie. Per. s angl. M.: Perrls; 2000. (In Russ.)
  4. Friedman A. Migrane and spannungscopfschmerz. Worl Neurology. 1961;2:45.
  5. Wolff HG. Headache and other head pain. New York: Oxford Univ. Press; 1963.
  6. Köhler T, Kosanic S. Are persons with migraine characterized by a high degree of ambition, orderliness, and rigidity? Pain. 1992;48(3):321-323. doi:10.1016/0304-3959(92)90079-q
  7. Huber D. Migraine--personality and coping mechanisms: a critical review. Psychother Psychosom Med Psychol. 2003;53(11):432-439. doi:10.1055/s-2003-43387
  8. Grigor'eva VN, Thostov ASh. Psihologicheskaja pomoshh' v nevrologii. N. Novgorod.: Izdatel'stvo Nizhegorodskoj gos. med. akademii; 2009. (In Russ.)
  9. Merikangas KR, Angst J, Isler H. Migraine and psychopathology: results of the Zurich cohort study of young adults. Arch Gen Psychiatry. 1990;47(9):849-853. doi:10.1001/archpsyc.1990.01810210057008
  10. Guillem E, Pelissolo A, Lepine JP. Mental disorders and migraine: epidemiologic studies. Encephale. 1999;25(5):436-442.
  11. Corchs F, Mercante JP, Guendler VZ, Vieira DS, Masruha MR, Moreira FR, Bernik M, Zukerman E, Peres MF. Phobias, other psychiatric comorbidities and chronic migraine. Arq Neuropsiquiatr. 2006;64(4):950-953. doi:10.1590/S0004-282X2006000600012
  12. Senaratne R, Van Ameringen M, Mancini C, Patterson B, Bennett M. The prevalence of migraine headaches in an anxiety disorders clinic sample. J Headache Pain. 2011;12(3):331-338. doi:10.1007/s10194-010-0290-4
  13. Mercante J, Peres M, Bernik M. Primary headaches in patients with generalized anxiety disorder. J Headache Pain. 2011;12(3):331-338. doi:10.1007/s10194-010-0290-4
  14. Osipova VV, Voznesenskaja TG. Komorbidnost' migreni: Obzor literatury i podhody k izucheniju. Zhurnal nevrologii i psihiatrii im. Korsakova. 2007;107(3):64-73. (In Russ.)
  15. Lampl C, Thomas H, Tassorelli C, Katsarava Z, Laínez JM, Lantéri-Minet M, Rastenyte D, Ruiz de la Torre E, Stovner LJ, Andrée C, Steiner TJ. Headache, depression and anxiety: associations in the Eurolight project. J Headache Pain. 2016;17:59. doi:10.1186/s10194-016-0649-2
  16. Stewart WF, Lipton RB, Celentano DD, Reed ML. Prevalence of migraine headache in the United States: relation to age, income, race and other sociodemographic factors. JAMA. 1992;267(1):64-69. doi:10.1001/jama.1992
  17. Stewart WF, Linet MS, Celentano DD. Migraine headaches and panic attacks. Psychosom Med. 1989;51(5):559-569. doi:10.1097/00006842-198909000-00007
  18. Marazziti D, Toni C, Pedri S, Bonuccelli U, Pavese N, Lucetti C, Nuti A, Muratorio A, Cassano G. B. Prevalence of headache syndromes in panic disorder. Int Clin Psychopharmacol. 14(4):247-251. doi:10.1097/00004850-199907000-00007
  19. Breslau N, Schultz LR, Stewart WF, Lipton R, Welch KM. Headache types and panic disorder: directionality and specificity. Neurology. 2001;56(3):350-354. doi:10.1212/wnl.56.3.350
  20. Wang SJ, Chen PK, Fuh JL. Comorbidities of migraine. Front Neurol. 2010;23(1):16. doi:10.3389/fneur.2010.00016
  21. Osipova VV. Migren': klinika, diagnostika i podhody k lecheniju. Farmateka. 2008;20:43-47. (In Russ.)
  22. Smitherman TA, Kolivas ED, Bailey JR. Panic disorder and migraine: comorbidity, mechanisms, and clinical implications. Headache. 2013;53(1):23-45. doi:10.1111/head.12004
  23. Nemiah JC, Sifnoes PE. Psychosomatic illness and problem of communication. Psychoter Psychosom. 1970;18:154-160. doi:10.1159/000286074
  24. Taylor GJ, Bagby RM. New trends in alexithymia research. Psychother Psychosom. 2004;73(2):68-77. doi:10.1159/000075537
  25. Morozova OG. Differencirovannyj podhod k lecheniju cervikogennoj golovnoj boli naprjazhenija. Ukraїns'kij vіsnik psihonevrologії. 2009;17(59):100-103. (In Russ.)
  26. Zhevneronok IV, Krjukova OV. Migren' bez aury v detskom vozraste: dinamika klinicheskih,nejrofiziologicheskih pokazatelej pri lechenii Noofenom. Nevrologija i nejrohirurgija. Vostochnaja Evropa. 2013;2(18):50-58. (In Russ.)
  27. Mehilane LS, Rjago LK, Allikmets LH. Farmakologija i klinika fenibuta. Tartu: TGU; 1990. (In Russ.)
  28. Burchinskij SG. K voprosu o mehanizmah anal'geticheskogo dejstvija nootropov: preparat Noofen. Lіki. 2005;5-6:10-13. (In Russ.)
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.